Transforming non-muscle invasive bladder cancer (NMIBC) treatment: FDA approval of Anktiva in combination with BCG. Khattak AA, Javed A, Pokhrel P, Mukhtar S, et al. Ann Med Surg (Lond) 2025;87:457-459.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Khattak AA, Javed A, Pokhrel P, Mukhtar S, et al. Transforming non-muscle invasive bladder cancer (NMIBC) treatment: FDA approval of Anktiva in combination with BCG. Ann Med Surg (Lond) 2025;87:457-459.
PMID: 40110262